More Bad News For CannTrust As Auditor Withdraws Reports


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Less than a month after cannabis producer CannTrust Holdings Inc (NYSE:CTST) was issued a noncompliance report from Canadian regulators for growing marijuana on unlicensed property, CannTrust investors received some more bad news on Friday when the company said its auditor has withdrawn all its recent financial statements.

Last week, CannTrust said its financial statements from 2018 and 2019 may need to be restated due to issues related to unlicensed operations. On Friday, CannTrust auditor KPMG withdrew the reports in question after CannTrust shared “newly uncovered information” with the auditors.

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Don’t miss out on the top cannabis stories of the day. Click here to sign up for our daily insider newsletter.

Why It’s Important

CannTrust investors must now interpret the vague language of the press release to try to get a grip on just how much of a financial impact the latest news will have on the company.

KPMG said it will remain on board as CannTrust’s auditor, but the company has said it may miss the filing deadline for its second-quarter earnings report. CannTrust also said KPMG was unaware of the licensing problems when it originally completed the reports and relied on representations made by individuals who are no longer employed by CannTrust.

“We will continue cooperating with our auditor and regulators, and take whatever steps are necessary to restore full trust in the Company's regulatory compliance,” CannTrust CEO Robert Marcovitch said in a statement.

What’s Next

CannTrust investors and cannabis investors in general are eager to put the licensing issue behind them. Canadian regulator Health Canada is conducting an ongoing investigation into CannTrust’s situation. Investors will be watching to see what type of penalties and/or fines Health Canada will ultimately impose on CannTrust and whether or not the company’s license is suspended or revoked.

CannTrust's stock traded lower by 4% to $2.16 at time of publication.

Benzinga's Cannabis Capital Conference heads to Detroit on Aug. 15 — click here to learn more!


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: CannabisNewsLegalMarketsHealth Canada